The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 02, 2022
Filed:
Apr. 22, 2014
Applicants:
Cytune Pharma, Nantes, FR;
Institut Gustave Roussy, Villejuif, FR;
Inventors:
David Bechard, Saint-Etienne de Montluc, FR;
Nathalie Chaput, Paris, FR;
Melanie Desbois, Maison Alfort, FR;
Assignees:
Cytune Pharma, Nantes, FR;
Institut Gustave Roussy (IGR), Villejuif, FR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/54 (2006.01); A61K 38/20 (2006.01); C07K 14/715 (2006.01); G01N 33/50 (2006.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
C07K 14/5443 (2013.01); A61K 38/20 (2013.01); A61K 47/642 (2017.08); C07K 14/7155 (2013.01); G01N 33/5011 (2013.01); G01N 33/5047 (2013.01); C07K 2319/00 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention relates to a pharmaceutical composition for treating a cancer or an infection in a subject by administrating an amount of an interleukin 15 (IL-15) derivative conjugate so as to induce a proliferation of natural killer cells (NK cells) which is the same or higher than the one obtained with high dose of interleukin-2 (HDIL-2); eventually associated with a pharmaceutically acceptable carrier.